Your GLP-1 Standard Treatment Plan includes submission of your prescription to your desired local pharmacy (or Lilly Direct, NovoCare), as well as unlimited support from your healthcare provider and patient support team for your treatment duration (until your next follow-up is due)
In a real-world study, patients averaged 8.7% at one year
Also ideal for those whose hair loss may be driven by chronic inflammation or poor tissue repair
The published SURMOUNT-1 data in adults without diabetes over 72 weeks, per Eli Lilly's disclosed trial information: 5mg dose: average weight loss of 15.0% of body weight (approximately 34 lbs) 10mg dose: average weight loss of 19.5% of body weight (approximately 44 lbs) 15mg dose: average weight loss of 20.9% of body weight (approximately 48 lbs) Placebo: average weight loss of 3.1% (approximately 7 lbs) Average starting weights ranged from 226.8 to 233.3 lbs across dose groups
Clinician adoption is rising as cardiology and endocrinology societies embed GLP-1 receptor agonists into secondary-prevention algorithms, while contract manufacturers race to alleviate pen-fill bottlenecks
It is one of the most extensively studied compounds in angiogenesis and wound-healing research, with models focusing on tendon-to-bone healing, new blood-vessel formation, and gastrointestinal tissue repair